Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 6 | 2025 | 169 | 2.000 |
Why?
|
| Macrophages | 6 | 2025 | 529 | 1.430 |
Why?
|
| Albuminuria | 3 | 2020 | 78 | 1.180 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 167 | 1.180 |
Why?
|
| Aortic Diseases | 2 | 2025 | 34 | 1.150 |
Why?
|
| Cell Proliferation | 4 | 2025 | 1455 | 1.070 |
Why?
|
| Nicotinamide N-Methyltransferase | 1 | 2025 | 1 | 0.950 |
Why?
|
| NAD | 1 | 2025 | 45 | 0.920 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2025 | 140 | 0.850 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2025 | 91 | 0.840 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2020 | 13 | 0.790 |
Why?
|
| Diabetic Nephropathies | 2 | 2023 | 78 | 0.770 |
Why?
|
| Endothelial Cells | 2 | 2024 | 329 | 0.700 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 107 | 0.680 |
Why?
|
| Apoptosis | 4 | 2025 | 1568 | 0.630 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 193 | 0.610 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 140 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 760 | 0.460 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 749 | 0.460 |
Why?
|
| Mice, Knockout | 5 | 2025 | 1035 | 0.410 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1596 | 0.410 |
Why?
|
| Diabetes Complications | 1 | 2014 | 102 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 1869 | 0.370 |
Why?
|
| Aorta | 2 | 2025 | 198 | 0.370 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 242 | 0.360 |
Why?
|
| Cell Count | 1 | 2011 | 145 | 0.340 |
Why?
|
| Podocytes | 1 | 2011 | 37 | 0.340 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 187 | 0.330 |
Why?
|
| Mice | 9 | 2025 | 6644 | 0.330 |
Why?
|
| Male | 12 | 2025 | 23409 | 0.270 |
Why?
|
| Nicotine | 2 | 2020 | 302 | 0.250 |
Why?
|
| Cells, Cultured | 4 | 2025 | 1621 | 0.250 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 263 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 1 | 2025 | 19 | 0.240 |
Why?
|
| Female | 9 | 2025 | 24698 | 0.230 |
Why?
|
| Methylamines | 1 | 2025 | 14 | 0.230 |
Why?
|
| Animals | 11 | 2025 | 16992 | 0.230 |
Why?
|
| Receptors, LDL | 2 | 2025 | 42 | 0.220 |
Why?
|
| Parathyroid Hormone | 1 | 2022 | 41 | 0.190 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 23 | 0.190 |
Why?
|
| Cholecalciferol | 1 | 2022 | 20 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 1 | 2022 | 36 | 0.190 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 65 | 0.180 |
Why?
|
| Aged | 4 | 2020 | 8214 | 0.180 |
Why?
|
| Vitamins | 1 | 2022 | 81 | 0.180 |
Why?
|
| Inflammation | 2 | 2024 | 758 | 0.180 |
Why?
|
| Creatinine | 2 | 2019 | 102 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2020 | 51 | 0.160 |
Why?
|
| Animal Feed | 1 | 2020 | 53 | 0.160 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 72 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2020 | 127 | 0.160 |
Why?
|
| Cadherins | 1 | 2020 | 102 | 0.160 |
Why?
|
| Humans | 10 | 2025 | 43102 | 0.160 |
Why?
|
| Urinalysis | 1 | 2019 | 34 | 0.150 |
Why?
|
| Middle Aged | 4 | 2020 | 12222 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 440 | 0.150 |
Why?
|
| Zinc Fingers | 1 | 2018 | 28 | 0.140 |
Why?
|
| Nicotinic Agonists | 1 | 2019 | 88 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2019 | 122 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 114 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 96 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 518 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2025 | 2157 | 0.130 |
Why?
|
| Adult | 3 | 2020 | 13872 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 150 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2020 | 863 | 0.130 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 5 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1078 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1063 | 0.120 |
Why?
|
| Giant Cells | 1 | 2015 | 15 | 0.120 |
Why?
|
| Osteoclasts | 1 | 2015 | 28 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 26 | 0.120 |
Why?
|
| Calcinosis | 1 | 2015 | 62 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2018 | 735 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 147 | 0.100 |
Why?
|
| Risk Factors | 1 | 2020 | 3994 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3156 | 0.090 |
Why?
|
| Microtomy | 1 | 2011 | 9 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 67 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 95 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 107 | 0.080 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2009 | 6 | 0.080 |
Why?
|
| gamma-MSH | 1 | 2009 | 4 | 0.080 |
Why?
|
| Estradiol | 1 | 2011 | 268 | 0.080 |
Why?
|
| United States | 1 | 2020 | 5205 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1723 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 934 | 0.070 |
Why?
|
| Follistatin | 1 | 2008 | 28 | 0.070 |
Why?
|
| Muscle Development | 1 | 2008 | 51 | 0.070 |
Why?
|
| beta Catenin | 1 | 2008 | 78 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 106 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 144 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 216 | 0.060 |
Why?
|
| Kidney | 1 | 2009 | 372 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1070 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2009 | 666 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2024 | 48 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2025 | 149 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2020 | 1003 | 0.050 |
Why?
|
| Osteopontin | 1 | 2023 | 46 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 5080 | 0.050 |
Why?
|
| Mecamylamine | 1 | 2020 | 21 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 29 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 129 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 105 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 142 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 139 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 99 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 44 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 536 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 191 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 183 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 694 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 532 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 181 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 3735 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 701 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 224 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 1177 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 2676 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 51 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1766 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 458 | 0.020 |
Why?
|
| Telemetry | 1 | 2009 | 14 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2009 | 33 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 70 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 22 | 0.020 |
Why?
|
| Proteinuria | 1 | 2009 | 56 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 277 | 0.020 |
Why?
|
| Sodium | 1 | 2009 | 102 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 18 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 20 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2853 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 37 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 296 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 456 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 883 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 383 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 436 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 386 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 638 | 0.010 |
Why?
|